Rigaku Holdings Corp (268A.T)
40 additional metrics available with a Kvantra account
No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | N/A | N/A | 62,701 | 79,887 | 90,652 | 94,193 | 93,033 | 102,106 |
| Operating profit | ¥m | ||||||||
| Net profit | ¥m | N/A | N/A | 911 | 10,904 | 13,615 | 11,401 | 9,256 | 13,746 |
| EPS reported | ¥ | ||||||||
| Operating cashflow per share | ¥ | ||||||||
| Capex per share | ¥ | ||||||||
| FCF per share | ¥ | ||||||||
| Free cash flow | ¥m | ||||||||
| Net debt | ¥m | ||||||||
| Book value equity | ¥m | ||||||||
| Book value per share | ¥ | ||||||||
| Number of shares | m | ||||||||
| DPS (TTM paid) | ¥ |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | ||||||||
| P/B LTM | x | ||||||||
| P/S LTM | x | ||||||||
| P/FCF LTM | x | ||||||||
| EV/EBITDA LTM | x | ||||||||
| EV/Sales LTM | x | ||||||||
| Earnings Yield LTM | % | ||||||||
| FCF Yield | % | ||||||||
| Quality | |||||||||
| ROE | % | ||||||||
| ROIC | % | ||||||||
| Operating margin | % | ||||||||
| Gross margin | % | ||||||||
| FCF/Sales | % | ||||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | ||||||||
| Sales Growth YoY | % | ||||||||
| Net Income Growth YoY | % | ||||||||
| FCF Growth | % | ||||||||
| Operating Profit Growth | % | ||||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | ||||||||
| Dividend Growth | % | ||||||||
| Payout Ratio | % | ||||||||
| FCF/Debt | x | ||||||||
| Net Debt/EBITDA | x | ||||||||
| EBIT/Net interest | x | ||||||||
| Net debt/market cap | % | ||||||||
| Net debt/Equity | % | ||||||||
| Gross debt/equity | % | ||||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Rigaku Holdings Corporation engages in the manufacture and sale of scientific equipment in Japan, the United States, Europe, and Asia. The company offers multipurpose analytical instruments, such as X-ray diffraction equipment, X-ray fluorescence, and X-ray imaging; semiconductor process control equipment, including semiconductor X-ray inspection and X-ray transmission equipment; and product-related warranty, repairs, maintenance, relocation, and other products. Its products are used in life science, academia, semiconductor electronic device, battery, and other applications. The company was founded in 1951 and is based in Akishima, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Rigaku Holdings Corporation engages in the manufacture and sale of scientific equipment in Japan, the United States, Europe, and Asia. The company offers multipurpose analytical instruments, such as X-ray diffraction equipment, X-ray fluorescence, and X-ray imaging; semiconductor process control equipment, including semiconductor X-ray inspection and X-ray transmission equipment; and product-related warranty, repairs, maintenance, relocation, and other products. Its products are used in life science, academia, semiconductor electronic device, battery, and other applications. The company was founded in 1951 and is based in Akishima, Japan.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free